FOLH1 and metastatic neoplasm: Third, high-volume centers may more routinely use advanced imaging, such as magnetic resonance imaging or prostate-specific membrane antigen positron emission tomography, which may result in stage migration by ruling out metastatic disease and overall better outcomes compared with staging by conventional imaging alone.